Phase ⅡStudy of Pinocembrin Injection to Treat Ischemic Stroke---Randomized, Double-blind, Placebo-controlled, Multicenter Study
Phase of Trial: Phase II
Latest Information Update: 22 Jun 2016
At a glance
- Drugs Pinocembrin (Primary)
- Indications Stroke
- Focus Therapeutic Use
- Sponsors CSPC ZhongQi Pharmaceutical Technology
- 16 Jun 2016 Planned End Date changed from 1 Jan 2015 to 1 Dec 2016.
- 16 Jun 2016 Planned primary completion date changed from 1 Jan 2015 to 1 Dec 2016.
- 16 Jun 2016 Status changed from recruiting to suspended.